Paul Medan

Dr. Paul Medan

Urology Department, Clinical Municipal Hospital, Cluj-Napoca, Romania
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2020 in Medicina
Verified
Journal Article
Open access
PDF file
CMClaudia-Gabriela Moldovanu
Claudia-Gabriela Moldovanu
B(Bianca Boca (Petresc)
Bianca Boca (Petresc)
ALAndrei Lebovici
Andrei Lebovici
ATAttila Tamas-Szora
Attila Tamas-Szora
MSMihai Domnutiu Suciu
Mihai Domnutiu Suciu
MBMircea Marian Buruian
Mircea Marian Buruian
Background and objectives: The use of non-invasive techniques to predict the histological type of renal masses can avoid a renal mass biopsy, thus being of great clinical interest. The aim of our study was to assess if quantitative multiphasic multidetector computed tomography (MDCT) enhancement patterns of renal masses (malignant and benign) may be useful to enable lesion differentiation by their enhancement characteristics. Materials and Methods: A total of 154 renal tumors were retrospectively analyzed with a four-phase MDCT protocol. We studied attenuation values using the values within the most avidly enhancing portion of the tumor (2D analysis) and within the whole tumor volume (3D analysis). A region of interest (ROI) was also placed in the adjacent uninvolved renal cortex to calculate the relative tumor enhancement ratio. Results: Significant differences were noted in enhancement and de-enhancement (diminution of attenuation measurements between the postcontrast phases) values by histology. The highest areas under the receiver operating characteristic curves (AUCs) of 0.976 (95% CI: 0.924–0.995) and 0.827 (95% CI: 0.752–0.887), respectively, were demonstrated between clear cell renal cell carcinoma (ccRCC) and papillary RCC (pRCC)/oncocytoma. The 3D analysis allowed the differentiation of ccRCC from chromophobe RCC (chrRCC) with a AUC of 0.643 (95% CI: 0.555–0.724). Wash-out values proved useful only for discrimination between ccRCC and oncocytoma (43.34 vs 64.10, p < 0.001). However, the relative tumor enhancement ratio (corticomedullary (CM) and nephrographic phases) proved useful for discrimination between ccRCC, pRCC, and chrRCC, with the values from the CM phase having higher AUCs of 0.973 (95% CI: 0.929–0.993) and 0.799 (95% CI: 0.721–0.864), respectively. Conclusions: Our observations point out that imaging features may contribute to providing prognostic information helpful in the management strategy of renal masses.

21 April 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
IAIulia Andras
Iulia Andras
ATAngelo Territo
Angelo Territo
TTTeodora Telecan
Teodora Telecan
PMPaul Medan
Paul Medan
IPIon Perciuleac
Ion Perciuleac
NCNicolae Crisan
Nicolae Crisan
(1) Introduction: The advent of robotic surgery led to the assumption that laparoscopic surgery would be replaced entirely. However, the high costs of robotic surgery limit its availability. The aim of the current study was to assess the feasibility of the 3D laparoscopic approach for the most complex urological procedures. (2) Materials and methods: We included in the current study all patients who had undergone complex 3D laparoscopic procedures in our department since January 2017, including radical nephrectomy (LRN) using a dual combined approach (19 patients), radical nephroureterectomy (LRNU) with bladder cuff excision (13 patients), and radical cystectomy (LRC) with intracorporeal urinary diversion (ICUD) (21 patients). (3) Results: The mean operative time was 345/230/478 min, the complications rate was 26%/30.76%/23.8% and positive surgical margins were encountered in 3/1/1 patients for the combined approach of LRN/LRNU/LRC with ICUD, respectively. A single patient was converted to open surgery during LRN due to extension of the vena cava thrombus above the hepatic veins. After LRC, sepsis was the most common complication and 8 patients were readmitted at a mean of 15.5 days after discharge. (4) Conclusions: In the era of robotic surgery, laparoscopy remains a plausible alternative for most complex oncological cases.

11 September 2024 in Medicina
Verified
Journal Article
Open access
PDF file
MBMaximilian Buzoianu
Maximilian Buzoianu
IAIulia Andras
Iulia Andras
LGLorin Giurgiu
Lorin Giurgiu
CMClaudia Militaru
Claudia Militaru
APAndrei Popa
Andrei Popa
NCNicolae Crisan
Nicolae Crisan
Synchronous prostatic adenocarcinoma found in patients with muscle-invasive bladder cancer (MIBC) that undergo radical cistoprostatectomy is not uncommon. Nonetheless, the occurrence of collision metastasis, where both prostate cancer and bladder cancer involve the same lymph node, is exceptionally uncommon, with few cases being reported in the literature. We present a case of a 65-year-old patient diagnosed with MIBC who underwent laparoscopic radical cistoprostatectomy with extended lymph node dissection and intracorporeal ileal conduit. The final pathology revealed urothelial carcinoma pT3bN1 as well as prostatic adenocarcinoma pT3bN1. One lymph node presented metastasis from both bladder cancer and prostate cancer.

11 October 2023 in Urology
Verified
Journal Article
Closed access
NCNicolae Crisan
Nicolae Crisan
IAIulia Andras
Iulia Andras
PMPaul Medan
Paul Medan
EPEduard Popovici
Eduard Popovici
CTCatalin Trifan
Catalin Trifan
ICIoan Coman
Ioan Coman

30 July 2026 in Asian Journal of Surgery
Verified
Journal Article
Open access
PMPaul Medan
Paul Medan
SMStefana-Arlinda Medan
Stefana-Arlinda Medan
IAIulia Andras
Iulia Andras
APAndrei Popa
Andrei Popa
ECEmanuel-Darius Cata
Emanuel-Darius Cata
NCNicolae Crisan
Nicolae Crisan

24 July 2018 in Medicine and Pharmacy Reports
Verified
Journal Article
Open access
PDF file
NCNicolae Crisan
Nicolae Crisan
IAIulia Andras
Iulia Andras
TTTeodora Telecan
Teodora Telecan
ASAndreea Szabo
Andreea Szabo
APAndrei Popa
Andrei Popa
ICIoan Coman
Ioan Coman
Laparoendoscopic single-site (LESS) approach has been successfully employed for a number of urologic procedures. The retroperitoneal approach further limits the working space and instrument movement during LESS surgery, but has the advantage of a faster post-operative recovery and lower complications rate. We present our first experience using retroperitoneal LESS approach for a renal cyst decortication in a 40-year-old patient. The operative time was 40 minutes, the blood loss was minimal and we did not encounter significant conflicts between the instruments. The patient was discharged 2 days after the procedure and returned to full normal activity within one week. We consider that the retroperitoneal LESS approach is feasible for upper tract urologic surgery. Pre-bent instruments might further improve surgical gestures and extend the indications for more complex procedures. Nevertheless, the advent of reusable devices is expected to increase the cost-effectiveness of LESS and expand its use.